-
Barca skipper Raphinha out against Getafe and Galatasaray
-
Djokovic crashes out of Shanghai Masters in his first match
-
MEXC and Payward Highlight Collaboration as Crypto and TradFi Converge at TOKEN2049
-
EU says Turkey's crackdown on rights hampers membership bid
-
EU states agree beefed-up European financial markets watchdog
-
Two Renoir paintings stolen in France recovered: mayor
-
Eritrea, Ethiopia trade barbs as Tigray rebels retreat
-
German leader outraged at Schroeder birthday visit to Putin
-
Kompany 'proud' of Man City success despite guilty verdict
-
Stocks up, oil retreats as Trump rules out pre-vote Iran attack
-
Man City will win appeal over financial charges, says Maresca
-
South African judge Navi Pillay wins Nobel Peace Prize
-
Fernandez logs record lap at Indonesia MotoGP practice
-
'I completely trust the club,' says Man City boss Maresca
-
Navi Pillay: S.Africa's global rights activist and Nobel winner
-
'10 out of 10' Quintana reminisces over dream Vuelta win
-
Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading
-
Maddinson given shock recall but fails to score
-
Russell goes fastest in practice for smoggy Singapore GP
-
Navi Pillay, South African rights champion, wins Nobel Peace Prize
-
For exiled Russian director Zvyagintsev, triumph without belonging
-
Saudi Arabia says three killed at airport as Yemen war expands
-
Home hope Zheng storms into China Open semi-finals
-
Everton's US owners mull sale of club two years after takeover
-
Zverev churns out win in Shanghai Masters opener
-
Ukraine takes Russia fight to 'scorching sands' of Sahel
-
Hurricane Isaias strengthens en route to US Gulf Coast
-
Chinese AI tool pulled to prevent 'misuse' after South Korea hacks
-
US activists deploy poll volunteers over Trump intimidation fears
-
Asian stocks mostly up as traders weigh AI, oil dips after surge
-
Saint Laurent designer Vaccarello leaves after glittering decade
-
Walking through flames: orangutans rescued in Indonesia fires
-
'Tough to stay here': Nepal flood survivors wait for homes
-
LeBron shines in pre-season debut for re-tooled 76ers
-
Malaysia closes schools in capital, parts of country due to haze
-
Okinawa resolution calls for revision of US forces pact after murder
-
Buccaneers stun Cowboys for first win of NFL season
-
Verdict expected Friday in Mexico trial over murders of Australia, US surfers
-
Activists hope trial will stop 'forever chemicals' at Italy plant
-
New York mayor says asking Trump to withdraw ICE after shooting
-
Guardians rally for 9-5 victory over White Sox to stay alive in MLB playoffs
-
Walking through flames: orangutan rescued in Indonesia fires
-
Asian stocks mixed amid AI concerns, oil dips after surge
-
James shines in pre-season debut for re-tooled 76ers
-
Wallabies expect fast-paced All Blacks in Bledisloe opener
-
Fuel, fertilizer costs strain US farmers' support for Republicans in midterms
-
Tech scammer Elizabeth Holmes focus of documentary by absurdist Nathan Fielder
-
Trump's 'super intelligence' rebrand to sell AI faces uphill battle
-
Climate hopes shift from politics to the courts
-
Fiji demands US provide evidence Chinese official paid bribes for Beijing
Lab-grown human 'embryos' offer new research hope
Scientists have developed human embryo-like structures without using sperm, an egg or fertilisation, offering hope for research on miscarriage and birth defects but also raising fresh ethical concerns.
Earlier this year, several labs around the world released pre-print studies describing their development of early human embryo-like structures.
That work has not yet been peer-reviewed, but now one group's research has been published in the journal Nature, describing how they coaxed human embryonic stem cells to self-organise into a model resembling an early embryo.
The research was welcomed by some scientists as an "impressive" advance that could help unlock secrets about the precarious early stages of pregnancies, when failure is most common.
The work will however renew debate on the need for clearer ethical rules on development of lab-grown human embryo models.
The researchers, led by Palestinian scientist Jacob Hanna at the Weizmann Institute in Israel, harnesses the power of embryonic stem cells, which can become any kind of cell.
They produced embryo models up to 14 days old, which is the legal limit for such research in many countries, and the point at which organs like the brain begin to develop.
The researchers say their work differs from those of other teams because it uses chemically rather than genetically modified embryonic stem cells and produces models more like real human embryos, complete with yolk sac and amniotic cavity.
These similarities could make the models more useful for research into conditions like miscarriage, birth defects and infertility, said James Briscoe of Britain's Francis Crick Institute.
The model "seems to produce all of the different types of cells that form tissues at this early stage of development," said Briscoe, principal group leader and associate research director at the biomedical research charity.
The research "is a step towards opening a window on the period of human development where many pregnancies fail and which has been really difficult to study up until now."
Both the researchers and scientists not involved in the work emphasised that the models should not be considered human embryos.
The structure "highly resembles, but (is) not identical, to the in utero situation", the research notes.
The success rate on generating the models was also low, with the stem cells organising correctly just a small percentage of the time.
Still, the research and other recent work shows "that models of human embryos are getting more sophisticated and closer to events that occur during normal development," said Darius Widera, an expert in stem cell biology at the UK's University of Reading.
The work highlights "that a robust regulatory framework is more needed than ever before", he added.
In Britain, Cambridge University has begun developing the first governance framework for stem cell-based human embryo models.
The Weizmann Institute research does not involve transferring the models into a human or animal womb, or developing the structures beyond 14 days.
D.Khalil--SF-PST